U.S. Interventional Oncology Market by Type (Radiation Therapy, Ablation Devices (Microwave Ablation, Radiofrequency Ablation, Cryoablation, and Others), and Particle Embolization Devices (Microcatheters and Guidewires)), by Cancer Type (Lung Cancer, Liver Cancer, Kidney Cancer, and Others), by End-user (Hospitals, Specialty Clinics, and Others), Forecast 2024-2032
The U.S. interventional oncology market is expected to reach USD 8.5 billion by 2028, growing at a CAGR of 7.8% from 2021 to 2028. The increasing prevalence of cancer, advancements in interventional oncology techniques, and a growing preference. Interventional oncology procedures comprise diagnosis and treatment of cancer with the help of minimally invasive procedures that are conducted under image guidance. The process utilizes equipment such as x-ray, ultrasound, computed tomography, or magnetic resonance imaging for guidance purposes. The interventional oncology procedures, the cancer is targeted and destroyed using image guidance for planning and execution. Such procedures are carried out in a state of the art oncology Cath Lab or under CT/USG guidance. The procedures are carried out using guide accessories and instruments, including ablation electrodes, guidewires, biopsy needles, and intravascular catheters that enable the treatment of a tumour situated in remote parts of the body. The rapidly growing field of interventional oncology has become a pillar of cancer care, along with medical, surgical and radiation oncology. The interventional oncology program uses targeted, minimally invasive procedures performed with the help of image guidance to diagnose, treat and/or relieve the symptoms of cancer.
Type:
Cancer Type:
End-user:
The U.S. interventional oncology market is highly competitive, with major players operating in various regions.
The detailed report on the U.S. Interventional Oncology Market provides an in-depth analysis of the market, including:
The report provides a detailed analysis of pricing trends in the U.S. Interventional Oncology market, including:
The report covers import and export trends in the U.S. Interventional Oncology market, including:
The report segments the U.S. Interventional Oncology market based on various criteria, including:
The report provides a comprehensive analysis of patents and trademarks in the U.S. Interventional Oncology market, including:
Aspects | Details |
---|---|
Study Period | 2018-2032 |
Base Year | 2023 |
Estimated Year | 2024 |
Forecast Period | 2024-2032 |
Historical Period | 2018-2023 |
Growth Rate | CAGR of 7.8% from 2018-2032 |
Segmentation |
|
Office no. A 5010, fifth floor, Solitaire Business Hub, Near Phoenix mall, Pune, Maharashtra 411014
Craig Francis
Business Development Head
+44 1223 92 666
sales@advancemarketanalytics.com
get latest updates and offers.